VBI Vaccines CEO Jeffrey Baxter's 2021 pay jumps 54% to $3.5M
VBI Vaccines reports 2021 executive compensation
By ExecPay News
Published: April 29, 2022
VBI Vaccines reported fiscal year 2021 executive compensation information on April 29, 2022.
In 2021, three executives at VBI Vaccines received on average a compensation package of $2.4M, a 52% increase compared to previous year.
Average pay of disclosed executives at VBI Vaccines
Jeffrey R. Baxter, Chief Executive Officer, received $3.5M in total, which increased by 54% compared to 2020. 70% of Baxter's compensation, or $2.4M, was in option awards. Baxter also received $368K in bonus, $605K in salary, as well as $67K in other compensation.
Francisco Diaz-Mitoma, Chief Medical Officer, received a compensation package of $1.9M, which increased by 52% compared to previous year. 65% of the compensation package, or $1.2M, was in option awards.
David E. Anderson, Chief Scientific Officer, earned $1.8M in 2021, a 49% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 29, 2022.